1. Use of argatroban: Experiences in continuous renal replacement therapy in critically ill patients after cardiac surgery 
Matthias Klingele, MD, Hagen Bomberg, MD, Anne Lerner-Gräber, MD, Danilo Fliser, MD, Aaron Poppleton, MD, Hans J. Schäfers, MD, Heinrich V. Groesdonk, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 147, Issue 6, Pages (June 2014)
DOI: /j.jtcvs
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
Need for transfusion, fluid balance, and hemoglobin within the first 3 days of continuous venovenous hemodialysis in patients receiving heparin or argatroban.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

3. Figure 2
Need for transfusion daily, duration of dialysis, and hemoglobin during dialysis period in patients receiving argatroban or heparin or who were switched from heparin to argatroban.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions